You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 12, 2024

List of Excipients in API atazanavir


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing atazanavir

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
ER Squibb & Sons LLC REYATAZ atazanavir 0003-3624 ALCOHOL
ER Squibb & Sons LLC REYATAZ atazanavir 0003-3624 AMMONIA
ER Squibb & Sons LLC REYATAZ atazanavir 0003-3624 BUTYL ALCOHOL
ER Squibb & Sons LLC REYATAZ atazanavir 0003-3624 CROSPOVIDONE
ER Squibb & Sons LLC REYATAZ atazanavir 0003-3624 FD&C BLUE NO. 2
ER Squibb & Sons LLC REYATAZ atazanavir 0003-3624 FERRIC OXIDE RED
ER Squibb & Sons LLC REYATAZ atazanavir 0003-3624 FERRIC OXIDE YELLOW
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing atazanavir

Company Ingredient NDC Excipient
Major Pharmaceuticals atazanavir 0904-6875 CROSPOVIDONE
Major Pharmaceuticals atazanavir 0904-6875 FD&C BLUE NO. 2
Major Pharmaceuticals atazanavir 0904-6875 FERRIC OXIDE RED
Major Pharmaceuticals atazanavir 0904-6875 FERRIC OXIDE YELLOW
Major Pharmaceuticals atazanavir 0904-6875 FERROSOFERRIC OXIDE
Major Pharmaceuticals atazanavir 0904-6875 GELATIN
Major Pharmaceuticals atazanavir 0904-6875 LACTOSE MONOHYDRATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for atazanavir

Excipient focus: ALCOHOL

Excipient focus: AMMONIA

Excipient focus: BUTYL ALCOHOL

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C RED NO. 28

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

atazanavir drug variants not containing FERRIC OXIDE YELLOW

Company Ingredient NDC
Cipla USA Inc atazanavir 69097-443
Amneal Pharmaceuticals NY LLC atazanavir 69238-1135
REMEDYREPACK INC atazanavir 70518-2832
Zydus Pharmaceuticals USA Inc atazanavir 70710-1050
Zydus Lifesciences Limited atazanavir 70771-1591
ER Squibb & Sons LLC atazanavir and cobicistat 0003-3641
Teva Pharmaceuticals USA Inc atazanavir sulfate 0093-5526
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: POTASSIUM HYDROXIDE

atazanavir drug variants not containing POTASSIUM HYDROXIDE

Company Ingredient NDC
ER Squibb & Sons LLC atazanavir 0003-3624
Avera McKennan Hospital atazanavir 69189-3624
Avera McKennan Hospital atazanavir 69189-3631
ER Squibb & Sons LLC atazanavir and cobicistat 0003-3641
Teva Pharmaceuticals USA Inc atazanavir sulfate 0093-5526
Golden State Medical Supply Inc atazanavir sulfate 51407-171
Physicians Total Care Inc atazanavir sulfate 54868-4857
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SORBITAN MONOLAURATE

Excipient focus: STEARIC ACID

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group